344 related articles for article (PubMed ID: 30044599)
21. Beneficial effects of suplatast tosilate (IPD-1151T) in a rat cystitis model induced by intravesical hydrochloric acid.
Kirimoto T; Nakano K; Irimura K; Hayashi Y; Matsuura N; Kiniwa M; Oka T; Yoshimura N
BJU Int; 2007 Oct; 100(4):935-9. PubMed ID: 17714534
[TBL] [Abstract][Full Text] [Related]
22. Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis?
Daha LK; Riedl CR; Lazar D; Hohlbrugger G; Pflüger H
Eur Urol; 2005 Mar; 47(3):393-7; discussion 397. PubMed ID: 15716206
[TBL] [Abstract][Full Text] [Related]
23. [A comparative analysis of intravesical sodium hyaluronate monotherapy and its combination with oral chondroitin sulfate in patietns with bladder pain syndrome/intersticial cystitis].
Aboyan IA; Aboyan VE; Pavlov SV; Zinkovskaya OV; Pavlov DS
Urologiia; 2019 Apr; (1):35-39. PubMed ID: 31184015
[TBL] [Abstract][Full Text] [Related]
24. Effect of diagnostic hydrodistension and four intravesical hyaluronic acid instillations on bladder ICAM-1 intensity and association of ICAM-1 intensity with clinical response in patients with interstitial cystitis.
Leppilahti M; Hellström P; Tammela TL
Urology; 2002 Jul; 60(1):46-51. PubMed ID: 12100920
[TBL] [Abstract][Full Text] [Related]
25. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis.
Morales A; Emerson L; Nickel JC; Lundie M
J Urol; 1996 Jul; 156(1):45-8. PubMed ID: 8648835
[TBL] [Abstract][Full Text] [Related]
26. [Experimental studies on microcirculatory inflammatory reactions of the urinary bladder].
Járomi P; Szabó A; Garab D; Bodnár D; Uhercsák G; Boros M; Hartmann P
Magy Seb; 2012 Aug; 65(4):184-90. PubMed ID: 22940386
[TBL] [Abstract][Full Text] [Related]
27. Intravesical hyaluronic acid and alkalinized lidocaine for the treatment of severe painful bladder syndrome/interstitial cystitis.
Lv YS; Zhou HL; Mao HP; Gao R; Wang YD; Xue XY
Int Urogynecol J; 2012 Dec; 23(12):1715-20. PubMed ID: 22576327
[TBL] [Abstract][Full Text] [Related]
28. Recent developments of intravesical therapy of painful bladder syndrome/interstitial cystitis: a review.
Toft BR; Nordling J
Curr Opin Urol; 2006 Jul; 16(4):268-72. PubMed ID: 16770126
[TBL] [Abstract][Full Text] [Related]
29. A systematic review and meta-analysis on the efficacy of intravesical therapy for bladder pain syndrome/interstitial cystitis.
Barua JM; Arance I; Angulo JC; Riedl CR
Int Urogynecol J; 2016 Aug; 27(8):1137-47. PubMed ID: 26590137
[TBL] [Abstract][Full Text] [Related]
30. Low energy shock wave therapy attenuates mitochondrial dysfunction and improves bladder function in HCl induced cystitis in rats.
Wang HJ; Tyagi P; Lin TK; Huang CC; Lee WC; Chancellor MB; Chuang YC
Biomed J; 2022 Jun; 45(3):482-490. PubMed ID: 34224911
[TBL] [Abstract][Full Text] [Related]
31. Gabapentin reduces painful bladder hypersensitivity in rats with lipopolysaccharide-induced chronic cystitis.
Yoshizumi M; Watanabe C; Mizoguchi H
Pharmacol Res Perspect; 2021 Feb; 9(1):e00697. PubMed ID: 33340266
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
Shie JH; Liu HT; Wang YS; Kuo HC
BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
[TBL] [Abstract][Full Text] [Related]
33. Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid.
Porru D; Campus G; Tudino D; Valdes E; Vespa A; Scarpa RM; Usai E
Urol Int; 1997; 59(1):26-9. PubMed ID: 9313320
[TBL] [Abstract][Full Text] [Related]
34. Treatment of interstitial cystitis with Cystistat: a hyaluronic acid product.
Kallestrup EB; Jorgensen SS; Nordling J; Hald T
Scand J Urol Nephrol; 2005; 39(2):143-7. PubMed ID: 16032779
[TBL] [Abstract][Full Text] [Related]
35. The Effects of Neurokinin-1 Receptor Antagonist in an Experimental Autoimmune Cystitis Model Resembling Bladder Pain Syndrome/Interstitial Cystitis.
Liu BK; Jin XW; Lu HZ; Zhang X; Zhao ZH; Shao Y
Inflammation; 2019 Feb; 42(1):246-254. PubMed ID: 30196377
[TBL] [Abstract][Full Text] [Related]
36. [Effectiveness and safety of intravesical hyaluronic acid for symptom control in chronic bladder diseases.].
Boronat Catalá J; García Tello A; González Montes L; Ruiz Graña S; Torres Pérez D; Llanes González L
Arch Esp Urol; 2021 Sep; 74(7):639-644. PubMed ID: 34472431
[TBL] [Abstract][Full Text] [Related]
37. Effect of intravesical tarantula cubensis extract (Theranekron) on inflammation in an interstitial cystitis rat model.
Abdullah A; Çiğdem Y; Tuğrul EE; Erhan A
Low Urin Tract Symptoms; 2023 Mar; 15(2):63-67. PubMed ID: 36478083
[TBL] [Abstract][Full Text] [Related]
38. Recommendations on the use of intravesical hyaluronic acid instillations in bladder pain syndrome.
Madurga Patuel B; González-López R; Resel Folkersma L; Machado Fernández G; Adot Zurbano JM; Bonillo MÁ; Vozmediano Chicharro R; Zubiaur Líbano C
Actas Urol Esp (Engl Ed); 2022 Apr; 46(3):131-137. PubMed ID: 35256323
[TBL] [Abstract][Full Text] [Related]
39. Intravesical sodium hyaluronate inhibits the rat urinary mast cell mediator increase triggered by acute immobilization stress.
Boucher WS; Letourneau R; Huang M; Kempuraj D; Green M; Sant GR; Theoharides TC
J Urol; 2002 Jan; 167(1):380-4. PubMed ID: 11743360
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of intravesical chondroitin-sulfate and combined hyaluronic-acid/chondroitin-sulfate therapy on female sexual function in bladder pain syndrome.
Arslan B; Gönültaş S; Gökmen E; Özman O; Avci MA; Özdemir E
Int Urogynecol J; 2019 Nov; 30(11):1857-1862. PubMed ID: 31254047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
